Katru dienu Latvij\u0101 vair\u0101k nek\u0101 57 000 iedz\u012bvot\u0101ju lieto vismaz vienu atkar\u012bbu izraiso\u0161u sedat\u012bvo vai prettrauksmes l\u012bdzekli, inform\u0113ja Skaida.<\/p>\n
Speci\u0101iste uzsv\u0113rusi, ka \u0161iem medikamentiem piem\u012bt sp\u0113c\u012bga nomierino\u0161a, anksiol\u012btiska un pretkrampju iedarb\u012bba, ta\u010du ilgsto\u0161a lieto\u0161ana var novest pie kognit\u012bviem trauc\u0113jumiem, demences riska un sare\u017e\u0123\u012btiem atcel\u0161anas simptomiem.<\/p>\n
Prezent\u0101cij\u0101 tika uzsv\u0113rta nepiecie\u0161am\u012bba p\u0113c stingras uzraudz\u012bbas un vienotas sist\u0113mas benzodiazep\u012bnu izrakst\u012b\u0161an\u0101, tostarp vienotas pacienta vieno\u0161an\u0101s formas, “e-vesel\u012bbas” datu izmanto\u0161anas un komandas pieejas \u0101rst\u0113\u0161an\u0101.<\/p>\n
Skaida rosin\u0101ja vair\u0101kas konkr\u0113tas darb\u012bbas, tostarp valsts l\u012bme\u0146a izmai\u0146as algoritmos, \u0101rst\u0113\u0161anas l\u012bgumu ievie\u0161anu un recep\u0161u p\u0101rskat\u012b\u0161anas k\u0101rt\u012bbu, k\u0101 ar\u012b uzsv\u0113ra \u0101rstniec\u012bbas personu apm\u0101c\u012bbu noz\u012bmi.<\/p>\n
Profesors M\u0101ris Bukovskis run\u0101ja par nikot\u012bna atkar\u012bbu. Vi\u0146\u0161 sav\u0101 prezent\u0101cij\u0101 “Sm\u0113\u0137\u0113\u0161anas diskr\u0113tais \u0161arms laikmetu grie\u017eos” ieskic\u0113jis gan sm\u0113\u0137\u0113\u0161anas v\u0113sturiskos aspektus un sabiedr\u012bbas attieksmes mai\u0146u, gan detaliz\u0113ti analiz\u0113jis m\u016bsdien\u0101s pieejam\u0101s \u0101rst\u0113\u0161anas metodes. \u012apa\u0161i vi\u0146\u0161 uzsv\u0113ris nepiecie\u0161am\u012bbu sm\u0113\u0137\u0113\u0161anu uztvert k\u0101 hronisku, bet \u0101rst\u0113jamu slim\u012bbu.<\/p>\n
Prezent\u0101cij\u0101 tika apl\u016bkoti da\u017e\u0101di zin\u0101tniski pamatoti sm\u0113\u0137\u0113\u0161anas atme\u0161anas risin\u0101jumi, tostarp nikot\u012bna aizst\u0101jterapija, bupropions, varenikl\u012bns un atjaunoti, dabiskas izcelsmes medikamenti, piem\u0113ram, citiz\u012bns.<\/p>\n
Bukovskis ar\u012b aicin\u0101ja \u0101rstus izstr\u0101d\u0101t re\u0101listiskus atme\u0161anas pl\u0101nus un izmantot pieejamos skr\u012bninga r\u012bkus, piem\u0113ram, Fagerstr\u0113ma testu, lai nov\u0113rt\u0113tu atkar\u012bbas pak\u0101pi un izv\u0113l\u0113tos atbilsto\u0161\u0101ko terapiju.<\/p>\n
L\u012bdztekus kl\u012bnisk\u0101 psiholo\u0123e Magdal\u0113na Iveta Pranaite konferenc\u0113 atkl\u0101ja, cik strauji Latvij\u0101 pieaug procesu atkar\u012bbas, \u012bpa\u0161i azartsp\u0113\u013cu un digit\u0101l\u0101s atkar\u012bbas. Vi\u0146a analiz\u0113ja aktu\u0101lo statistiku, kas r\u0101dot, ka Latvij\u0101 vair\u0101k nek\u0101 34 000 cilv\u0113ku iek\u013cauti Pa\u0161atteiku\u0161os sp\u0113l\u0113t\u0101ju re\u0123istr\u0101, bet pal\u012bdz\u012bbas pieejam\u012bba joproj\u0101m ir fragment\u0101ra.<\/p>\n","protected":false},"excerpt":{"rendered":"Katru dienu Latvij\u0101 vair\u0101k nek\u0101 57 000 iedz\u012bvot\u0101ju lieto vismaz vienu atkar\u012bbu izraiso\u0161u sedat\u012bvo vai prettrauksmes l\u012bdzekli, inform\u0113ja…\n","protected":false},"author":2,"featured_media":11677,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[23,28,29,32,33,22,30,31,35,39,38,36,37,34,40,4257,20,4258,26,27,24,25,21],"class_list":{"0":"post-11676","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-aktualitates","8":"tag-aktualitates","9":"tag-breaking-news","10":"tag-breakingnews","11":"tag-featured-news","12":"tag-featurednews","13":"tag-headlines","14":"tag-latest-news","15":"tag-latestnews","16":"tag-latvia","17":"tag-latvian","18":"tag-latviesu","19":"tag-latviesu-valoda","20":"tag-latviesuvaloda","21":"tag-latvija","22":"tag-lv","23":"tag-nacionalais-psihiskas-veselibas-centrs","24":"tag-news","25":"tag-npvc","26":"tag-popularakas-zinas","27":"tag-popularakaszinas","28":"tag-top-stories","29":"tag-topstories","30":"tag-zinas"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/11676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=11676"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/11676\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/11677"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=11676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=11676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=11676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}